Efficacy and Safety of Adalimumab in Moderately to Severely Active Cases of Ulcerative Colitis: A Meta-Analysis of Published Placebo-Controlled Trials

BACKGROUND/AIMS: To evaluate the efficacy and safety of adalimumab (ADA) in moderately to severely active ulcerative colitis (UC) patients who are unresponsive to traditional therapy. METHODS: Electronic databases, including the PubMed, Embase, and Cochrane databases, were searched to April 20, 2014...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zong Mei, Li, Wei, Jiang, Xue Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of Gut and Liver 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4780457/
https://www.ncbi.nlm.nih.gov/pubmed/26780088
http://dx.doi.org/10.5009/gnl15042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4780457/
https://www.ncbi.nlm.nih.gov/pubmed/26780088
http://dx.doi.org/10.5009/gnl15042

Ejemplares similares